Unbranded office poster for Pfizer's comirnaty Covid-19 vaccine co-marketed with Marvel Comics
View PDF
View PDF
Forest Laboratories. Unbranded campaign for launch of new beta-blocker treatment, Nebivolol, for hypertension (Agency: Grey Healthcare)
Forest Laboratories. Unbranded campaign concept to launch, Nebivolol, a new beta-blocker treatment for hypertension (Agency: Grey Healthcare)
Myviva (JAZZ Pharmaceuticals). Unbranded HCP mailer using patient pain scale (smiley face chart) that focuses on symptoms of fibromyalgia and Xyrem. (Agency: OgilvyInteractive)
Xyrem was found to treat patients suffering from fibromyalgia. Second page from Myviva (JAZZ Pharmaceuticals). Detail from unbranded mailer continued. (Agency: OgilvyInteractive)
Page 3 of Myviva Unbranded Mailer - HCP
Final page of Myviva Unbranded Mailer - description
Grazax (Schering-Plough). Initial campaign for launch of a sublingual antigen-focused hay fever and blue grass allergy treatment (Agency: LLNS)
Xifaxan (rifaximin) tablets contain rifaximin, a non-aminoglycoside semi-synthentic antibiotic indicated in the treatment of hepatic encephalopothy. This banner campaign was used in the launch of the new indication
Banner ads for Xifaxan (treatment for hepatic encephalopathy)
Physician hand-out for Nayzilam (treatment for epileptic episodes)
Unbranded campaign for Ultomiris, a treatment for NMOSD
Campaign for Novartis non-small cell lung cancer campaign stressing inflammation (agency: Merkely)
gLike
HCP/DTC Campaigns
Fibromyalgia is a chronic disorder characterized by soft-tissue painful response to pressure. It is often misdiagnosed by HCPs. JAZZ Pharmaceutical provided mailers aimed at HCPs for Myviva (aka Xyrem) to help diagnose the disease
View Website